Neurological and Neurodegenerative Conditions Neurological applications remain highly preliminary based on animal model studies
This is not a diet
Liraglutide and semaglutide can induce nausea, vomiting, diarrhea, constipation, dyspepsia, abdominal pain, bloating, belching, gastroesophageal reflux disease (GERD), dry mouth, gastritis, hypoglycemia, injection site reactions (redness and itching), fatigue, weakness, dizziness, taste changes, sleep disturbances, gallstones, and elevated lipase/amylase levels
(Source: AAOPM, April 2026) Where GLP-1s Sit on Formulary Tiers UnitedHealthcare, the largest commercial insurer in the United States, generally places GLP-1 receptor agonists on Tier 4 (specialty) or Tier 5 (non-preferred specialty) the tiers carrying the highest copay or coinsurance amounts
Injectable Testosterone comes in several ester forms
Almatroodi SA, Alsahli MA, Almatroudi A, et al